Bay Street News, October 28th, 2019

GERMANTOWN, Md., Oct. 28, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a leading cell and […]

BURLINGTON, Mass., and DENVER, Oct. 28, 2019 (GLOBE NEWSWIRE) — At the American College of Emergency Physicians (ACEP) conference, Nuance […]

LAGOS, Nigeria, Oct. 28, 2019 (GLOBE NEWSWIRE) — Opera Limited (NASDAQ: OPRA), one of the world’s major browser developers and […]

Enrollment in MOMENTUM Phase 3 migraine trial of AXS-07 in patients with history of inadequate response nearly complete; on track […]

~ Announced Completion of Full Patient Enrollment in HOPE-B Pivotal Study of Etranacogene Dezaparvovec ~~ Achieved Site Initiation and Began […]

-Provides update from ongoing Phase 1/2 clinical trials of CTX001® for patients with severe hemoglobinopathies--Began treating patients in Phase 1/2 […]

Highlights:Net sales of $253.8 million, up 2.4% compared to $248.0 million in Q3 2018.Diluted earnings per share (EPS) on a […]

TORONTO, Oct. 28, 2019 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX / TSX : CDV) (“Cardinal” or “the Company”) is […]

TORONTO, Oct. 28, 2019 (GLOBE NEWSWIRE) — NextSource Materials Inc. (TSX:NEXT) (OTCQB:NSRCF) (“NextSource” or the “Company”) announces it has completed […]

EDMONTON, Alberta, Oct. 28, 2019 (GLOBE NEWSWIRE) — Alcanna Inc. (the “Company”) (TSX:”CLIQ”) announced today that it plans to release […]